Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.
暂无分享,去创建一个
D J van Veldhuisen | H S Koops | M. P. van den Berg | E. D. de Vries | E. de Vries | J. Gietema | P. Willemse | D. V. van Veldhuisen | W. Sluiter | N. Mulder | D T Sleijfer | M P van den Berg | E G de Vries | W T van der Graaf | W J Sluiter | M. T. Meinardi | M T Meinardi | J A Gietema | M A Runne | P B Willemse | N H Mulder | H. Koops | D. Sleijfer | J. Gietema | W. V. D. van der Graaf | MP van den Berg | M. Runne | M. Meinardi | D. van Veldhuisen | WT van Graaf | Marina Runne | PB Willemse | N. Mulder | P. Willemse
[1] P. Hall,et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. , 1997, Journal of the National Cancer Institute.
[2] L. Badano,et al. Reproducibility of wall motion score and its correlation with left ventricular ejection fraction in patients with acute myocardial infarction. , 1996, The American journal of cardiology.
[3] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[4] E. Gehan,et al. Dose‐response and dose‐survival advantage for high versus low‐dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study , 1984, Cancer.
[5] A. Bleasel,et al. Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. V. van Oosterom,et al. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Tattersall,et al. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] L. Wilkins. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .
[9] D. Berman,et al. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime. , 1991, Circulation.
[10] J. Thomas,et al. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. , 1996, Journal of the American College of Cardiology.
[11] J. Grygiel,et al. Hypercholesterolemia after chemotherapy for testis cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] G. Bosl,et al. Pituitary and testicular hormonal function after treatment for germ cell tumours. , 1987, International journal of andrology.
[13] K. Flegal,et al. Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991 , 1994 .
[14] D. Levy,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[15] D. Kerr,et al. Long-term sequelae of treatment for testicular germ cell tumours. , 1990, British Journal of Cancer.
[16] M. Roberts,et al. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. , 1988, Journal of the American College of Cardiology.
[17] L. Einhorn,et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] L. Collette,et al. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] S. W. Hansen,et al. Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] R. Sylvester,et al. Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group. , 1995, British Journal of Cancer.
[21] W. Whitmore,et al. VAB‐3 combination chemotherapy of metastatic testicular cancer , 1981, Cancer.
[22] L. Einhorn,et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. , 1987, The New England journal of medicine.
[23] L. Einhorn,et al. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] R. Grundy,et al. Long-term toxicity of chemotherapy for testicular cancer--the cost of cure. , 1990, British Journal of Cancer.
[25] G. Bosl,et al. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. , 1981, Annals of internal medicine.
[26] J. Ghali,et al. The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery Disease , 1992, Annals of Internal Medicine.
[27] D. Stablein,et al. No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] C. Bokemeyer,et al. Endocrinological late effects after chemotherapy for testicular cancer. , 1996, British Journal of Cancer.
[29] L. Einhorn,et al. Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] H. Parving. Microalbuminuria in essential hypertension and diabetes mellitus , 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[31] C. Bokemeyer,et al. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer. , 1995, European journal of cancer.
[32] J. Caro. Clinical review 26: Insulin resistance in obese and nonobese man. , 1991, The Journal of clinical endocrinology and metabolism.
[33] H. von der Maase,et al. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] L. Collette,et al. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer. , 1998, British Journal of Cancer.
[35] C. Mogensen,et al. Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.
[36] C. Bokemeyer,et al. Evaluation of long-term toxicity after chemotherapy for testicular cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] R. Sylvester,et al. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] J. Vanoverschelde,et al. Asynchronous (segmental early) relaxation impairs left ventricular filling in patients with coronary artery disease and normal systolic function. , 1991, Journal of the American College of Cardiology.
[39] D. Levy,et al. Echocardiographic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (the Framingham Heart Study). , 1993, The American journal of cardiology.
[40] C. Jackson,et al. MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.
[41] N. Geller,et al. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] J. Laragh,et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.
[43] J. Hainsworth,et al. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. , 1986, Annals of internal medicine.
[44] C. Logothetis,et al. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. , 1986, The American journal of medicine.
[45] K. Heimdal,et al. Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer. , 1995, Oncology.
[46] P. Steiner,et al. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. , 1978, Clinical chemistry.
[47] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[48] G. Dell'omo,et al. Microalbuminuria and endothelial dysfunction in essential hypertension , 1994, The Lancet.
[49] E. D. de Vries,et al. Long-term Follow-up of Cardiovascular Risk Factors in Patients Given Chemotherapy for Disseminated Nonseminomatous Testicular Cancer , 1992, Annals of Internal Medicine.
[50] M. Josephson. Treatment of ventricular arrhythmias after myocardial infarction. , 1986, Circulation.
[51] N. Geller,et al. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.